Attack Chain

1. Attacker gains low-privileged network access to the Oracle Life Sciences Empirica Signal server via HTTP.
2. Attacker crafts a malicious HTTP request targeting the vulnerable Common Core component.
3. The crafted request bypasses authentication or authorization checks due to the vulnerability.
4. The server processes the malicious request, allowing the attacker to perform unauthorized actions.
5. Attacker gains unauthorized read access to a subset of Oracle Life Sciences Empirica Signal accessible data.
6. Attacker gains unauthorized creation, deletion, or modification access to critical data within Empirica Signal.
7. The vulnerability's scope change allows the attacker to potentially impact additional, related Oracle products.

Impact

Successful exploitation of CVE-2026-21997 can lead to unauthorized access, modification, deletion, and creation of sensitive data within Oracle Life Sciences Empirica Signal. While the number of potential victims is unknown, organizations using the affected versions (9.2.1-9.2.3) are at risk. The vulnerability's scope change indicates a potential for broader impact, affecting other Oracle Life Science Applications and jeopardizing the confidentiality and integrity of critical research data and patient information.

Recommendation

• Apply the security patch provided by Oracle to address CVE-2026-21997 on all Oracle Life Sciences Empirica Signal instances (versions 9.2.1-9.2.3).
• Implement the Sigma rule "Detect CVE-2026-21997 Exploitation Attempt via HTTP" to monitor for suspicious HTTP requests targeting the Common Core component of Oracle Life Sciences Empirica Signal based on cs-uri-query and cs-method.
• Review and harden access controls for Oracle Life Sciences Empirica Signal to minimize the potential impact of low-privileged attackers, based on the vulnerability description.